• Elpiscience, Bio-Techne to develop anti-cancer therapeutics

    • April 25, 2019
    • Posted By : admin
    • 0 Comment
    •   97 views

    Elpiscience BioPharma and Bio-Techne Corporation have announced that the companies have entered into a strategic collaboration for the development of anti-cancer therapeutics.

    Under the terms of the agreement, Elpiscience will have access to multiple antibodies from Bio-Techne’s extensive product portfolio for use in the development of preclinical, clinical, and commercial biopharmaceuticals.

    The collaboration between Elpiscience, a China based biotech company committed to leading the innovation and development of the next generation of cancer immunotherapy, and Bio-Techne, a global leader in life sciences and molecular diagnostics, will expand mutual capabilities in the field of cancer immunotherapy.

    This strategic collaboration also aims to accelerate the development of new biologics to address unmet medical needs in oncology.

  97 views

You Might Also Like

No comments found

LEAVE COMMENT

Archive

Offers
error: Content is protected !!